These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 15124213)

  • 21. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
    Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
    Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel heparin-coated hydrophilic preparation of amphotericin B hydrosomes.
    Clemons KV; Ranney DF; Stevens DA
    Curr Opin Investig Drugs; 2001 Apr; 2(4):480-7. PubMed ID: 11566003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectroscopic investigation of the aggregation state of amphotericin B during loading, freeze-drying, and reconstitution of polymeric micelles.
    Adams M; Kwon GS
    J Pharm Pharm Sci; 2004 Nov; 7(4):1-6. PubMed ID: 15850542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of liposomal amphotericin B formulation.
    Gulati M; Bajad S; Singh S; Ferdous AJ; Singh M
    J Microencapsul; 1998; 15(2):137-51. PubMed ID: 9532520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid membrane-binding properties of amphotericin B deoxycholate (Fungizone) using surface plasmon resonance.
    Oka M; Kamimori H
    Anal Sci; 2013; 29(7):697-702. PubMed ID: 23842411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The formation of amphotericin B ion channels in lipid bilayers.
    Fujii G; Chang JE; Coley T; Steere B
    Biochemistry; 1997 Apr; 36(16):4959-68. PubMed ID: 9125518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noncovalent complexation of amphotericin-B with Poly(α-glutamic acid).
    Mohamed-Ahmed AH; Les KA; Seifert K; Croft SL; Brocchini S
    Mol Pharm; 2013 Mar; 10(3):940-50. PubMed ID: 23234235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploitation of lectinized lipo-polymerosome encapsulated Amphotericin B to target macrophages for effective chemotherapy of visceral leishmaniasis.
    Gupta PK; Asthana S; Jaiswal AK; Kumar V; Verma AK; Shukla P; Dwivedi P; Dube A; Mishra PR
    Bioconjug Chem; 2014 Jun; 25(6):1091-102. PubMed ID: 24842628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal activity of amphotericin B conjugated to carbon nanotubes.
    Benincasa M; Pacor S; Wu W; Prato M; Bianco A; Gennaro R
    ACS Nano; 2011 Jan; 5(1):199-208. PubMed ID: 21141979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescence of amphotericin B-deoxycholate (fungizone) monomers and aggregates and the effect of heat-treatment.
    Stoodley R; Wasan KM; Bizzotto D
    Langmuir; 2007 Aug; 23(17):8718-25. PubMed ID: 17637009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of aggregation and ionization in the chemical instability of Amphotericin B in aqueous methanol.
    Sawangchan P; Alexandrino Júnior F; Alencar ÉN; Egito EST; Kirsch LE
    Int J Pharm; 2023 Feb; 632():122586. PubMed ID: 36623739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of free and liposomal amphotericin B with renal proximal tubular cells in primary culture.
    Joly V; Saint-Julien L; Carbon C; Yeni P
    J Pharmacol Exp Ther; 1990 Oct; 255(1):17-22. PubMed ID: 2213553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity.
    Adams ML; Andes DR; Kwon GS
    Biomacromolecules; 2003; 4(3):750-7. PubMed ID: 12741794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
    Falamarzian A; Lavasanifar A
    Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of the selective toxicity of amphotericin B incorporated into liposomes.
    Juliano RL; Grant CW; Barber KR; Kalp MA
    Mol Pharmacol; 1987 Jan; 31(1):1-11. PubMed ID: 3807887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amphotericin B-copper(II) complex as a potential agent with higher antifungal activity against Candida albicans.
    Chudzik B; Tracz IB; Czernel G; Fiołka MJ; Borsuk G; Gagoś M
    Eur J Pharm Sci; 2013 Aug; 49(5):850-7. PubMed ID: 23791641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative toxicities and pharmacokinetics of intrathecal lipid (amphotericin B colloidal dispersion) and conventional deoxycholate formulations of amphotericin B in rabbits.
    Clemons KV; Sobel RA; Williams PL; Stevens DA
    Antimicrob Agents Chemother; 2001 Feb; 45(2):612-5. PubMed ID: 11158765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
    Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ
    J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A photophysical study on the role of bile salt hydrophobicity in solubilizing amphotericin B aggregates.
    Selvam S; Andrews ME; Mishra AK
    J Pharm Sci; 2009 Nov; 98(11):4153-60. PubMed ID: 19283765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerosolized liposomal amphotericin B: prediction of lung deposition, in vitro uptake and cytotoxicity.
    Fauvel M; Farrugia C; Tsapis N; Gueutin C; Cabaret O; Bories C; Bretagne S; Barratt G
    Int J Pharm; 2012 Oct; 436(1-2):106-10. PubMed ID: 22814222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.